Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Foundation Medicine (FMI)

Foundation Medicine (FMI)
136.95 -0.05 (-0.04%) 07/31/18 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Tue, Jul 31st, 2018
Day Low
136.95
Day High
136.95
Open 136.95
Previous Close 137.00 137.00
Volume 2,500 2,500
Avg Vol 651,095 651,095
Stochastic %K 81.55% 81.55%
Weighted Alpha +210.80 +210.80
5-Day Change +0.15 (+0.11%) +0.15 (+0.11%)
52-Week Range 31.70 - 137.20 31.70 - 137.20
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,088,180
  • Shares Outstanding, K 37,140
  • Annual Sales, $ 152,900 K
  • Annual Income, $ -161,470 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.09
  • Price/Sales 33.23
  • Price/Cash Flow N/A
  • Price/Book 268.62
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.21
  • Most Recent Earnings $-1.02 on 05/02/18
  • Next Earnings Date 08/07/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate -1.12
  • Number of Estimates 1
  • High Estimate -1.12
  • Low Estimate -1.12
  • Prior Year -1.24
  • Growth Rate Est. (year over year) +9.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
136.55 +0.29%
on 07/02/18
Period Open: 136.70
137.00 -0.04%
on 07/30/18
+0.25 (+0.18%)
since 06/29/18
3-Month
65.80 +108.13%
on 05/04/18
Period Open: 76.35
137.20 -0.18%
on 06/19/18
+60.60 (+79.37%)
since 04/30/18
52-Week
31.70 +332.02%
on 08/02/17
Period Open: 36.35
137.20 -0.18%
on 06/19/18
+100.60 (+276.75%)
since 07/28/17

Most Recent Stories

More News
TwinStrand Biosciences Announces $50 Million Series B to Expand the Adoption of its Duplex Sequencing Technology in Applications Requiring the Highest Sensitivity and Accuracy

TwinStrand Biosciences, the pioneer and developer of Duplex Sequencing, an ultra-high accuracy technology for revealing exceptionally low-frequency genetic variants, today announced that it has closed...

FMI : 136.95 (-0.04%)

Business Summary

Foundation Medicine, Inc. provides molecular information products primarily in the United States. The company offers FoundationOne(TM) a molecular information product for the analysis of routine cancer specimens in a clinical setting. Its molecular information platform generates actionable genomic information...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 137.17
1st Resistance Point 137.08
Last Price 136.95
1st Support Level 136.83
2nd Support Level 136.67
3rd Support Level N/A

See More

52-Week High 137.20
Last Price 136.95
Fibonacci 61.8% 96.90
Fibonacci 50% 84.45
Fibonacci 38.2% 72.00
52-Week Low 31.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.